ESSENS – Hyperglycemia Trial
(Blood Sugar)
STUDY AIMS
STUDY POPULATION
TRIAL REGISTRATION
PATIENT VISITS
STUDY END POINTS
RESULTS
COMMITTEE & INVESTIGATORS
EXECUTIVE COMMITTEE
INVESTIGATORS
CENTRAL LAB & CRO
CONTACT
ESSENS-HYPERLIPIDEMIA TRIAL
(Cholesterol)
STUDY AIMS
STUDY POPULATION
TRIAL REGISTRATION
PATIENT VISITS
STUDY END POINTS
RESULTS
COMMITTEE & INVESTIGATORS
EXECUTIVE COMMITTEE
INVESTIGATORS
CENTRAL LAB & CRO
CONTACT
E
valuation
S
eries on
S
afety and
E
fficacy of
N
utritional
S
upplements
ESSENS-HYPERGLYCEMIA TRIAL
STUDY END POINTS
Primary Study Objectives
To assess the Efficacy and Safety of PreCrea ® by:
Measuring reduction % changes of HbA1c from baseline to the end of supplementation after 03 months and,
Evaluating safety and tolerability by measuring changes in baseline renal function and liver function tests
Secondary Study Objectives
Percentage of Subjects achieving HbA1c < 7.0 %
To assess reduction % changes of fasting plasma glucose (FPG) from baseline to end of first month and at the end of supplementation after 03 months.
